InMode - INMD Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INMD shares.
View INMD analyst ratings or view top-rated stocks.

5 brokerages have issued 1-year price targets for InMode's stock. Their INMD share price forecasts range from $40.00 to $60.00. On average, they expect the company's stock price to reach $46.17 in the next twelve months. This suggests a possible upside of 32.2% from the stock's current price.
View analysts price targets for INMD or view top-rated stocks among Wall Street analysts.

InMode's stock was trading at $35.70 on January 1st, 2023. Since then, INMD stock has decreased by 2.2% and is now trading at $34.92.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our INMD earnings forecast.

InMode will be holding an earnings conference call on Tuesday, February 14th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "3700075".

InMode Ltd. (NASDAQ:INMD) issued its quarterly earnings data on Tuesday, October, 26th. The healthcare company reported $0.55 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.05. The healthcare company earned $94.18 million during the quarter, compared to analyst estimates of $89.38 million. InMode had a net margin of 40.93% and a trailing twelve-month return on equity of 39.52%. The company's revenue was up 57.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.31 earnings per share.

Shares of InMode split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were payable to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

InMode updated its FY 2023 earnings guidance on Wednesday, January, 11th. The company provided EPS guidance of for the period. The company issued revenue guidance of $525.00 million-$530.00 million, compared to the consensus revenue estimate of $523.86 million.

1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL).

(INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

InMode trades on the NASDAQ under the ticker symbol "INMD."

InMode's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Migdal Insurance & Financial Holdings Ltd. (1.07%), Peregrine Capital Management LLC (0.56%), Redwood Investments LLC (0.53%), ARK Investment Management LLC (0.08%), Anderson Hoagland & Co. (0.07%) and Whittier Trust Co. (0.07%).

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of INMD stock can currently be purchased for approximately $34.92.

InMode (NASDAQ:INMD) has a market capitalization of $2.91 billion and generates $357.57 million in revenue each year. The healthcare company earns $164.97 million in net income (profit) each year or $2.07 on an earnings per share basis.

The company employs 362 workers across the globe.

InMode's mailing address is TAVOR BUILDING SHAAR YOKNEAM POB 533, YOKNEAM L3, 2069200. The official website for the company is www.inmodemd.com. The healthcare company can be reached via phone at 972-4909-7470 or via email at ir@inmodemd.com.